Related Articles
Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma
Amplification of the NSD3‑BRD4‑CHD8 pathway in pelvic high‑grade serous carcinomas of tubo‑ovarian and endometrial origin
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer
FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome
STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer